Contact your GP or prescribing clinician if you experience : Severe or worsening cognitive impairment that significantly affects daily functioning, work performance, or safety (e.g., difficulty driving) Sudden onset of confusion or disorientation Memory loss that is progressive or concerning Cognitive symptoms accompanied by other neurological signs such as severe headache, visual disturbances, weakness, numbness, or speech difficulties Symptoms suggestive of hypoglycaemia (particularly if taking other diabetes medications): shakiness, sweating, rapid heartbeat, confusion, or loss of consciousness Signs of severe dehydration : reduced urination, dark urine, dizziness, rapid heartbeat, or extreme thirst Mood changes including significant depression, anxiety, or suicidal thoughts Persistent symptoms that do not improve with supportive measures after 24 weeks Your healthcare provider will conduct a thorough assessment, which may include: Clinical history and medication review Physical examination including neurological assessment Blood tests to evaluate glucose levels, electrolytes, kidney function, thyroid function, vitamin B12, folate, and other relevant parameters Blood pressure monitoring Consideration of alternative diagnoses Depending on findings, management may involve adjusting the Wegovy dose, temporarily discontinuing treatment, addressing nutritional deficiencies, or investigating other potential causes

Moderate (The "Mush & Push") Symptom: You are backed up, uncomfortable, and the stool feels hard
Patience during the introduction period prevents this outcome
These advances continue to expand the potential applications of GANs, particularly in fields that demand high-quality synthetic data
Ferulic acid esters and Withanolides: in search of Withania somnifera GABA(a) receptor modulators
The clinical results from supervised 503A compounded GHK-Cu are not comparable to results from unverified online purchases